CNN on MSN9d
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
according to the US Centers for Disease Control and Prevention The clinical trial tested the efficacy of Ozempic when added ...
infectiousdiseaseadvisor.com1d
Ozempic Approval Expanded to Include T2D Patients With Chronic Kidney Disease
The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.
6abc News8d
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
according to the US Centers for Disease Control and Prevention The clinical trial tested the efficacy of Ozempic when added to the standard of care, not as a replacement for other treatments for ...